Minke Smits

5PUBLICATIONS
36CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 09, 2025
Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses.

Stefan G van Ravensteijn, Jacco J de Haan, Hans Gelderblom

|Jan 20, 2022
Responsiveness to Immune Checkpoint Inhibitors Is Associated With a Peripheral Blood T-Cell Signature in Metastatic Castration-Resistant Prostate Cancer.

Donjete Simnica, Minke Smits, Edith Willscher

|Jun 17, 2021
Reovirus mutant jin-3 exhibits lytic and immune-stimulatory effects in preclinical human prostate cancer models.

Arjanneke F van de Merbel, Geertje van der Horst, Maaike H van der Mark

|Dec 17, 2020
Prior PSMA PET-CT Imaging and Hounsfield Unit Impact on Tumor Yield and Success of Molecular Analyses from Bone Biopsies in Metastatic Prostate Cancer.

Minke Smits, Kamer Ekici, Samhita Pamidimarri Naga

|Oct 01, 2020
Probing single-cell metabolism reveals prognostic value of highly metabolically active circulating stromal cells in prostate cancer.

Francesca Rivello, Kinga Matuła, Aigars Piruska

Pageof 1

Frequent Collaborators

4 joint publications

Niven Mehra

1 joint publications

Francesca Rivello

1 joint publications

Kinga Matuła

1 joint publications

Wilhelm T S Huck